Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire (PRECO-CI)

ANRS, Emerging Infectious Diseases

Status: Completed

Conditions: HIV Infection

Study type: Observational

Funder types: Other

Identifiers

NCT01917175

ANRS 1220/12277 PRECO-CI

Details and patient eligibility

About

Set-up of a biobank for patients with an estimated date of infection seroconverters: store plasma and cells samples at initial contact and during follow-up for future analysis and analysis in international collaborative cohort seroconverters.

Enrollment: 511 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients included in the last Primo-CI ANRS 1220 protocol
• All HIV infected individuals diagnosed during a blood donation with an estimated date of HIV seroconversion that will respect the following criteria: (i) age ≥18 (ii) HIV-1 or HIV-1+2 infected, (iii) HIV-seronegative at the preceding donation; (iv) who returned to the clinic to be informed of their HIV test result (v) with an HIV serology confirmed with two specific tests in two different laboratories (vi) who have never received ART for curative purpose
• informed on study objectives and have a signed informed consent.

Exclusion criteria

• Patient living outside of Abidjan

Trial design

511 participants in 1 patient group

HIV+ patients with an estimated date of seroconversion

Description:

It was estimated that 564 individuals, will be enrolled at the Blood Bank Medical Centre, including 364 individuals already followed-up (former PRIMOCI ANRS 1220 cohort started in 1997) and 200 newly enrolled individuals in this study.